Sapco Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 07-12-2024
- Paid Up Capital ₹ 1.22 Cr
as on 07-12-2024
- Company Age 30 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.20 M
as on 07-12-2024
- Satisfied Charges ₹ 1.57 M
as on 07-12-2024
- Revenue 64.59%
(FY 2022)
- Profit 363.49%
(FY 2022)
- Ebitda 254.74%
(FY 2022)
- Net Worth 5.54%
(FY 2022)
- Total Assets 22.91%
(FY 2022)
About Sapco Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.22 Cr.
The company currently has active open charges totaling ₹7.20 M. The company has closed loans amounting to ₹1.57 M, as per Ministry of Corporate Affairs (MCA) records.
Gonupalli Venkatasaiprasad, Gonupalli Suneelchand, and Padmavathi Gonupalli serve as directors at the Company.
- CIN/LLPIN
U24231TN1994PTC028966
- Company No.
028966
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Oct 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sapco Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gonupalli Venkatasaiprasad  | Director | 09-Nov-2000 | Current |
| Gonupalli Suneelchand | Director | 29-May-1998 | Current |
| Padmavathi Gonupalli | Director | 09-May-1998 | Current |
Financial Performance of Sapco Laboratories.
Sapco Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 64.59% increase. The company also saw a substantial improvement in profitability, with a 363.49% increase in profit. The company's net worth moved up by a moderate rise of 5.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sapco Laboratories?
In 2019, Sapco Laboratories had a promoter holding of 66.43% and a public holding of 33.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Karur Vysya Bank Limited Creation Date: 31 Mar 2004 | ₹7.20 M | Open |
The Karur Vysya Bank Limited Creation Date: 23 Dec 2013 | ₹0.60 M | Satisfied |
The Karur Vysya Bank Limited Creation Date: 31 Oct 2013 | ₹0.48 M | Satisfied |
How Many Employees Work at Sapco Laboratories?
Sapco Laboratories has a workforce of 30 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sapco Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sapco Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
